Unknown

Dataset Information

0

Ad26.COV2.S boosts antibody and T-cell responses following BNT162b2 vaccination.

ABSTRACT:

SUBMITTER: Iketani S 

PROVIDER: S-EPMC8635656 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Comparative analysis of human immune responses following SARS-CoV-2 vaccination with BNT162b2, mRNA-1273, or Ad26.COV2.S.
| S-EPMC9258461 | biostudies-literature
Unknown Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19.
| S-EPMC8282116 | biostudies-literature
Unknown Bell's palsy following the Ad26.COV2.S COVID-19 vaccination.
| S-EPMC8244554 | biostudies-literature
Unknown Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination.
| S-EPMC8063883 | biostudies-literature
Unknown Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data.
| S-EPMC8547775 | biostudies-literature
Unknown Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination.
| S-EPMC8314733 | biostudies-literature
Unknown Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients.
| S-EPMC8477622 | biostudies-literature
Unknown Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naive and Recovered Individuals Following mRNA Vaccination.
| S-EPMC7941668 | biostudies-literature
Unknown Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination - Response from the Manufacturer.
| S-EPMC8117965 | biostudies-literature
Unknown Lymphohistocytic myocarditis after Ad26.COV2.S viral vector COVID-19 vaccination.
| S-EPMC8421108 | biostudies-literature